These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9860115)

  • 1. Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization.
    Henry DJ; Hu XT; White FJ
    Psychopharmacology (Berl); 1998 Nov; 140(2):233-42. PubMed ID: 9860115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens.
    Henry DJ; White FJ
    J Pharmacol Exp Ther; 1991 Sep; 258(3):882-90. PubMed ID: 1890623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens.
    Hu XT; Koeltzow TE; Cooper DC; Robertson GS; White FJ; Vezina P
    Synapse; 2002 Sep; 45(3):159-70. PubMed ID: 12112395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
    Pierce RC; Born B; Adams M; Kalivas PW
    J Pharmacol Exp Ther; 1996 Jul; 278(1):384-92. PubMed ID: 8764374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
    Gong W; Neill DB; Lynn M; Justice JB
    Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of D1/D2 dopamine receptors within the nucleus accumbens and ventral tegmental area in the development of sensitization to antinociceptive effect of morphine.
    Reisi Z; Bani-Ardalan M; Zarepour L; Haghparast A
    Pharmacol Biochem Behav; 2014 Mar; 118():16-21. PubMed ID: 24418216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations.
    Li Y; Hu XT; Berney TG; Vartanian AJ; Stine CD; Wolf ME; White FJ
    Synapse; 1999 Dec; 34(3):169-80. PubMed ID: 10523754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration.
    Henry DJ; Greene MA; White FJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):833-9. PubMed ID: 2557418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor sub-types involvement in nucleus accumbens and ventral tegmentum but not in medial prefrontal cortex: on self-stimulation of lateral hypothalamus and ventral mesencephalon.
    Singh J; Desiraju T; Raju TR
    Behav Brain Res; 1997 Jul; 86(2):171-9. PubMed ID: 9134152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of repeated cocaine administration on dopamine D1 receptor modulation of mesocorticolimbic GABA and glutamate transmission.
    Steketee JD; Liu K
    Brain Res; 2018 Nov; 1698():106-113. PubMed ID: 30075100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer.
    Phillips GD; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1994 Mar; 114(2):345-59. PubMed ID: 7838928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased mesolimbic dopaminergic signaling underlies the waning of maternal caregiving across the postpartum period in rats.
    Grieb ZA; Vitale EM; Morrell JI; Lonstein JS; Pereira M
    Psychopharmacology (Berl); 2020 Apr; 237(4):1107-1119. PubMed ID: 31927604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1-D2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA).
    Rahman S; McBride WJ
    J Neurochem; 2001 Jun; 77(5):1248-55. PubMed ID: 11389175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine.
    Bjijou Y; Stinus L; Le Moal M; Cador M
    J Pharmacol Exp Ther; 1996 May; 277(2):1177-87. PubMed ID: 8627530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine.
    Wolf ME; White FJ; Hu XT
    J Neurosci; 1994 Mar; 14(3 Pt 2):1735-45. PubMed ID: 8126567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.